McKinsey to pay $550m settlement over marketing advice to opioid drugmakers
Consulting company officials issued a formal apology for their work with opioid makers and distributors in December
04 February 2021 - 17:16
Delaware — McKinsey & Co has agreed to pay more than $550m to settle say by US states that the consulting company helped fuel the opioid epidemic by providing marketing advice to drugmakers including Purdue Pharma and Johnson & Johnson, people familiar with the accord said.
New York-based McKinsey will pay about 80% of the money immediately to beef up treatment programmes and bolster police budgets strained by expanded abuse of the addictive painkillers, according to the people, who asked not to be identified because they weren’t authorised to speak publicly. The rest would be paid over four years. ..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.